Orchid Chemicals has reached an out-of-court settlement with world’s largest drugmaker Pfizer Inc to sell a low-cost version of the America...

The product has a global market size of about USD 2.4 billion for the twelve months ending September 2010 according to IMS study group.

Aurobindo Pharma on Thursday said it has received tentative approval from the US health regulator to market its generic Venlafaxine capsule...

Sun Pharmaceutical Industries’ plan to launch a copy of US-based Wyeth’s blockbuster anti-depressant capsule Effexor XR got a big boost aft...

PINC has hiked its target price for Sun Pharma to Rs 1,070 from Rs 973, citing one time opportunities from generic drugs like Oxaliplatin a...

India Infoline maintains the `Reduce’ rating on Sun Pharma with the price target of Rs 1,108 as the stock remains richly valued.

Macquarie Research has given an ‘outperform’ rating to Sun Pharmaceuticals, after it received a US-Food and Drug Administration nod for sel...

Lupin has struck an out-of-court settlement with Wyeth relating to the foreign company’s antidepressant ‘Effexor XR’ capsules.

Brokerage Sharekhan has picked Aban Offshore, Bharti Airtel, Grasim Industries, Hindustan Unilever, ITC, Larsen & Toubro, Maruti Suzuki, Ra...

Religare Research has maintained ‘buy’ on Sun Pharmaceutical Industries for a revised target of Rs 1,664 (Rs 1,347 previously), based on 18...

Religare Securities has maintained 'buy' on Sun Pharmaceutical for target price of Rs 1,347, based on 24 times FY09 estimates, which yields...

Wyeth’s decision to issue a covenant ‘not-to-sue’ (CNS) to Sun Pharmaceutical Industries for seeking approval to sell its version of anti-d...

Sun Pharmaceutical Industries has received a covenant ‘not to sue’ from Wyeth over Sun Pharma’s abbreviated new drug application for generi...